Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Svalöf Weibull was a prominent Swedish agricultural biotechnology and seed company formed in 1993 through the merger of Svalöf AB and W. Weibull AB. Headquartered in Svalöv, Sweden, the company specialized in the development and marketing of high-quality seed varieties for northern climates, focusing on crops such as wheat, barley, oats, and oilseeds. It utilized advanced biotechnological methods, including marker-assisted selection and genetic research, to improve crop yield and stress resistance. The company was a key player in European agricultural research and collaborated on significant projects like the development of genetically modified starch potatoes. In 2006, the company was rebranded as Lantmännen SW Seed and was eventually fully integrated into the Lantmännen Group. Its legacy continues through Lantmännen's agricultural division, which remains a leader in European plant genetics and seed production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Svalöf Weibull.